Mettler Toledo (MTD) cash flow statement

Life Sciences Tools & Services · NYSE · Health Care

$1,713 -0.83% Close Nov 17, 2026 Live

TrendArc score 69 of 100 · Health 8.2 · Momentum 8.9 · Moat 6.4 · scored Nov 17, 2026 · How the score works

Free cash flow, fiscal year to December 31, 2025

$849 million

down 2.0% from the year before

Mettler Toledo generated $849 million of free cash flow in the fiscal year to December 2025: $956 million of cash from operations less $107 million of capital spending. That was 21.1% of revenue, against 22.4% the year before. Over the last four quarters, to September 30, 2026, it was $871 million.

What stands out

  • Over the five fiscal years to December 2025 it paid $4.5 billion in net share repurchases, 110% of its free cash flow over the same years.
  • Diluted shares outstanding fell 14.6% over the five fiscal years to December 2025.

Each sentence is written by a fixed rule from the figures on this page.

Free cash flow and net income, the last 10 fiscal years

$250M$500M$750M$1.00B2016201720182019202020212022202320242025$337MFree cash flow $849MNet income $869M$250M$500M$750M$1.00B20172019202120232025Free cash flow $849MNet income $869M

Fiscal years, each labelled by the calendar year it ended in. Every figure is in the statement below.

Where the cash wentFiscal year to December 31, 2025

  1. Cash from operations 956
  2. Capital spending -107
  3. Free cash flow 849
  4. Businesses bought and sold, net -94
  5. Investments bought and sold, net 6
  6. Net share repurchases -768
  7. Debt and other 14
  8. Net change in cash 8

In millions of US dollars. Outflows are grey, not red: a buyback is not a loss. "Debt and other" closes the gap to the reported change in cash. Buying marketable securities moves cash into short-term investments; the balance sheet shows both.

Cash flow statement, the last 10 fiscal years

In millions of US dollars. Each column is a fiscal year, named by the month it ended; the first column adds up the last four quarters. Cash paid out is a negative number.
Fiscal year toLast 4 quarters
to Sep 2026
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating activities
Net income869863789873769603561513376384
Depreciation and amortisation1261231211131089989857669
Stock-based pay2323201820201918181715
Working capital and other items-62-3838-146125-65-5048-8
Cash from operations984956968966859909725603565516461
Investing activities
Capital spending-114-107-102-104-121-104-89-96-135-115-124
Businesses bought and sold, net-94-10-6-38-221-6-2-6-108-111
Investments bought and sold, net60630000000
Cash from investing-194-119-132-139-314-100-99-139-217-231
Financing activities
Debt issued or repaid, net21-193036039252586459312
Shares issued less bought back-750-768-826-881-1,067-980-748-727-450-371-475
Dividends paid00000000000
Cash from financing-755-856-860-716-591-744-477-388-320-164
Exchange rate effect1-3-1-6063-911-6
Net change in cash8-10-26-34-1143029-1060
Free cash flow
Free cash flow871849866861738805635508430401337
Free cash flow margin20.7%21.1%22.4%22.7%18.8%21.6%20.6%16.9%14.7%14.7%13.4%
Free cash flow per share$41.05$40.62$39.20$32.49$34.31$26.25$20.32$16.70$15.19$12.48

Shares issued less bought back is the cash from shares sold less the cash paid for shares bought back (negative when more was bought back), and includes tax withheld when employees' shares vest. Working capital and other items is cash from operations less net income, depreciation and amortisation, and stock-based pay (calculated by TrendArc). Company filings as standardised by Tiingo; calculations by TrendArc. Rebuilt nightly.

Mettler Toledo against its peers

CompanyFiscal year toFree cash flowFree cash flow margin
Bio-TechneTECH Jun 2026$263M21.7%
IlluminaILMN Dec 2025$931M21.4%
Mettler ToledoMTD Dec 2025$849M21.1%
WatersWAT Dec 2025$543M17.1%
Agilent TechnologiesA Oct 2025$1.15B16.6%
IQVIAIQV Dec 2025$2.13B13.0%
Charles River LaboratoriesCRL Dec 2025$518M12.9%
Peer median16.9%

Each company's newest fiscal year; some end in other months. The peers are the stock card's peer group.

Next

Follow Mettler Toledo with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes Mettler Toledo from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.